STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] IBEX Ltd Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

David Martin Afdahl, Chief Operating Officer of IBEX Ltd (IBEX), reported a non-discretionary sale of 403 common shares on 08/26/2025 at $29.13 per share. The filing states the sale was required to cover tax withholding arising from the vesting of restricted stock units and not a discretionary trade. After the transaction, the reporting person beneficially owned 54,986 common shares directly. The Form 4 was filed as a single-person filing and is signed by an attorney-in-fact.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine tax-withholding sale by an officer; not indicative of discretionary disposition.

The Form 4 documents a small, routine disposition of 403 shares at $29.13 to satisfy tax withholding tied to RSU vesting. This type of transaction is common following equity vesting events and the filer explicitly states it was not discretionary. The remaining direct beneficial ownership of 54,986 shares is disclosed, enabling transparency about insider holdings. No derivative or additional equity grants are reported in this filing.

TL;DR: Proper Section 16 disclosure of an officer sale for tax obligations; governance process appears followed.

The report identifies the reporting person as the COO and shows the sale was processed to cover tax withholding associated with RSU vesting. The presence of an attorney-in-fact signature suggests administrative handling consistent with corporate governance practices. The filing does not indicate other related-party transactions or changes in control; it serves as routine compliance with insider reporting rules.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Afdahl David Martin

(Last) (First) (Middle)
C/O IBEX LIMITED
1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)
WASHINGTON DC 20006

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 08/26/2025 S(1) 403 D $29.13 54,986 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and do not represent discretionary trades by the Reporting Person.
Remarks:
Lisa Lenstrohm, Attorney-in-Fact 09/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Ibex Ltd

NASDAQ:IBEX

IBEX Rankings

IBEX Latest News

IBEX Latest SEC Filings

IBEX Stock Data

468.12M
12.63M
13.05%
94.32%
0.95%
Information Technology Services
Services-computer Processing & Data Preparation
Link
United States
WASHINGTON